vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and STAG Industrial, Inc. (STAG). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $224.2M, roughly 1.2× STAG Industrial, Inc.). STAG Industrial, Inc. runs the higher net margin — 27.6% vs 0.7%, a 26.9% gap on every dollar of revenue. On growth, STAG Industrial, Inc. posted the faster year-over-year revenue change (9.1% vs -16.5%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Stag Arms is a firearms manufacturer founded in May 2003 and located in Cheyenne, Wyoming. Stag Arms is a manufacturer of the AR-15 type rifle, marketed as Stag-15 rifles. Stag advertises that all their weapons and accessories are made in the United States. They are best known for their left-handed AR-15 rifles, which use a mirror imaged upper receiver and have the ejection port reversed for left-handed shooters and the safety selector control on the right side of the lower receiver.
HCM vs STAG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $224.2M |
| Net Profit | $2.0M | $62.0M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | — |
| Net Margin | 0.7% | 27.6% |
| Revenue YoY | -16.5% | 9.1% |
| Net Profit YoY | -83.6% | — |
| EPS (diluted) | $0.00 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $224.2M | ||
| Q4 25 | $270.8M | $220.9M | ||
| Q3 25 | — | $211.1M | ||
| Q2 25 | $277.7M | $207.6M | ||
| Q1 25 | $324.5M | $205.6M | ||
| Q4 24 | — | $199.3M | ||
| Q3 24 | — | $190.7M | ||
| Q2 24 | $305.7M | $189.8M |
| Q1 26 | — | $62.0M | ||
| Q4 25 | $2.0M | $83.5M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | $455.0M | $50.0M | ||
| Q1 25 | $11.9M | $91.4M | ||
| Q4 24 | — | $51.0M | ||
| Q3 24 | — | $41.9M | ||
| Q2 24 | $25.8M | $59.8M |
| Q1 26 | — | — | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | -13.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -5.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -9.0% | — |
| Q1 26 | — | 27.6% | ||
| Q4 25 | 0.7% | 37.8% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | 163.8% | 24.1% | ||
| Q1 25 | 3.7% | 44.5% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 21.9% | ||
| Q2 24 | 8.4% | 31.5% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $8.9M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $3.6B |
| Total Assets | $1.8B | $7.2B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $8.9M | ||
| Q4 25 | $1.4B | $14.9M | ||
| Q3 25 | — | $17.3M | ||
| Q2 25 | $1.4B | $15.4M | ||
| Q1 25 | $836.1M | $9.3M | ||
| Q4 24 | — | $36.3M | ||
| Q3 24 | — | $70.0M | ||
| Q2 24 | $802.5M | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | $3.3B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | $93.4M | $3.0B | ||
| Q1 25 | $82.8M | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | $82.1M | $2.8B |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $1.2B | $3.6B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | $1.2B | $3.4B | ||
| Q1 25 | $759.9M | $3.5B | ||
| Q4 24 | — | $3.5B | ||
| Q3 24 | — | $3.3B | ||
| Q2 24 | $740.1M | $3.3B |
| Q1 26 | — | $7.2B | ||
| Q4 25 | $1.8B | $7.2B | ||
| Q3 25 | — | $6.9B | ||
| Q2 25 | $1.8B | $6.8B | ||
| Q1 25 | $1.3B | $6.8B | ||
| Q4 24 | — | $6.8B | ||
| Q3 24 | — | $6.6B | ||
| Q2 24 | $1.3B | $6.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | 0.91× | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | 0.08× | 0.88× | ||
| Q1 25 | 0.11× | 0.87× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | 0.11× | 0.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | 3.9% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $104.5M | ||
| Q3 25 | — | $143.5M | ||
| Q2 25 | $-72.9M | $111.9M | ||
| Q1 25 | $40.3M | $103.5M | ||
| Q4 24 | — | $104.9M | ||
| Q3 24 | — | $128.0M | ||
| Q2 24 | $-39.8M | $122.2M |
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $43.8M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | $-82.2M | $62.3M | ||
| Q1 25 | $32.5M | $57.2M | ||
| Q4 24 | — | $37.6M | ||
| Q3 24 | — | $86.7M | ||
| Q2 24 | $-49.9M | $105.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 19.8% | ||
| Q3 25 | — | 45.2% | ||
| Q2 25 | -29.6% | 30.0% | ||
| Q1 25 | 10.0% | 27.8% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | — | 45.5% | ||
| Q2 24 | -16.3% | 55.3% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 1.8% | 27.4% | ||
| Q3 25 | — | 22.7% | ||
| Q2 25 | 3.3% | 23.9% | ||
| Q1 25 | 2.4% | 22.5% | ||
| Q4 24 | — | 33.8% | ||
| Q3 24 | — | 21.6% | ||
| Q2 24 | 3.3% | 9.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | 1.25× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | -0.16× | 2.24× | ||
| Q1 25 | 3.38× | 1.13× | ||
| Q4 24 | — | 2.06× | ||
| Q3 24 | — | 3.06× | ||
| Q2 24 | -1.54× | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
